Table 1.
Residue2 | ||||||
---|---|---|---|---|---|---|
gp1 | Slice | Start | Stop | Mw3 | SC4 | SC/Mw5 |
84 | 10 | 11* | 413(C) | 45.7 | 34 | 0.7 |
86 | 8 | 123* | 428(C) | 35.4 | 47 | 1.3 |
89N | 1 | 1 | 122* | 13.1 | 18 | 1.4 |
89C | 5 | 156* | 387(C) | 26.1 | 117 | 4.5 |
92 | 10 | 86* | 440(C) | 41.1 | 11 | 0.3 |
93 | 7 | 157* | 435(C) | 30.9 | 177 | 5.7 |
94N | 1 | 12* | 95* | 9.2 | 11 | 1.2 |
94M | 1 | 96* | 275* | 20.1 | 15 | 0.7 |
94C | 5 | 276* | 505(C) | 26.4 | 14 | 0.5 |
95 | 7 | 261* | 547(C) | 31.6 | 177 | 5.6 |
96 | 8 | 66* | 371(C) | 34.9 | 6 | 0.2 |
97N | 14* | 66* | 5.8 | 24 | 4.1 | |
97C | 7 | 533* | 816(C) | 30.7 | 152 | 5.0 |
120, capsid | 12 | 164* | 747(C) | 64.9 | 1672 | 25.8 |
129N | 3 | 1 | 262* | 29.3 | 5 | 0.2 |
129C, portal | 12 | 263* | 896(C) | 70.1 | 89 | 1.3 |
153 | 5 | 53* | 304(C) | 28.2 | 42 | 1.5 |
162N | 3/4 | 18* | 137* | 13.2 | 41 | 3.1 |
162C | 6 | 259* | 522(C) | 29.0 | 156 | 5.4 |
163 | 8 | 55* | 395(C) | 38.1 | 45 | 1.2 |
175 | 4 | 1 | 210* | 23.7 | 39 | 1.6 |
177N | 1 | 1 | 60* | 6.4 | 9 | 1.4 |
177C | 11 | 61* | 519(C) | 52.4 | 126 | 2.4 |
180_180_2 | 12 | 1 | 505 | 57.8 | 36 | 0.6 |
184N | 3 | 1 | 108* | 12.1 | 6 | 0.5 |
184C | 1 | 109* | 230 | 13.2 | 21 | 1.6 |
203 | 12 | 1 | 653* | 75.3 | 71 | 0.9 |
303N | 8 | 61 | 268 | 22.8 | 38 | 1.7 |
303M | 1 | 269 | 366(C) | 11.1 | 17 | 1.5 |
303C | 7 | 367 | 646(C) | 31.3 | 62 | 2.0 |
The gene product name is appended with N (for N-terminal), M (for middle), or C (for C-terminal) when more than one segment of a gene product were detected in the virion.
A coordinate is appended with an * if confirmed by a semi-tryptic spectrum, or by (C) for an end defined by the stop codon. Semi-tryptic spectrum assignments were above 95% confidence except as noted in Supplementary Table 2.
The molecular weight (MW) was calculated from the sequence.
Peptide spectral counts (SC) were summed over all slices.
SC/MW values were calculated as an approximate indicator of abundance of the polypeptides per virion.